Adaptive Oxygen Therapeutics for Specialized Environments

Publication ID: 24-11857627_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Oxygen Therapeutics for Specialized Environments,” Published Technical Disclosure No. 24-11857627_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857627_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,627.

Summary of the Inventive Concept

An oxygen therapeutic system designed for treating glioblastoma in unique operational environments, such as high-altitude areas, disaster zones, remote locations, high-security facilities, or areas with limited medical infrastructure.

Background and Problem Solved

The original patent disclosed the use of an oxygen therapeutic in combination with repeated administrations of chemotherapy medications and/or radiation therapy. However, the existing approach may not be effective in specialized environments where oxygen levels are compromised or medical resources are limited. The new inventive concept addresses these limitations by adapting the oxygen therapeutic for use in these niche environments.

Detailed Description of the Inventive Concept

The inventive concept comprises a perfluoropentane emulsion administration module, which can be integrated with radiation therapy modules, power sources, and remote monitoring systems. The system is designed to operate in extreme weather conditions, high-altitude environments, and areas with limited medical infrastructure. The perfluoropentane emulsion is administered concomitantly with fractionated radiotherapy or chemotherapy, and the system can be adapted for secure, encrypted communication in high-security environments. The portable, self-contained treatment unit enables administration of the emulsion in disaster-stricken areas.

Novelty and Inventive Step

The new claims introduce novel adaptations of the oxygen therapeutic system for specialized environments, including high-altitude areas, disaster zones, remote locations, high-security facilities, or areas with limited medical infrastructure. The inventive step lies in the integration of the perfluoropentane emulsion administration module with radiation therapy modules, power sources, and remote monitoring systems, enabling effective treatment of glioblastoma in these unique operational environments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include adapting the oxygen therapeutic system for use in other specialized environments, such as space exploration or underwater operations. Variations of the system may also include different types of oxygen therapeutics or administration methods.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare industry, particularly in areas with limited medical infrastructure or high-security environments. The system may also be of interest to government agencies, disaster relief organizations, and remote medical providers.

CPC Classifications

SectionClassGroup
A A61 A61K41/0038
A A61 A61K9/0019
A A61 A61K9/107
A A61 A61K31/02
A A61 A61K33/00
A A61 A61K39/395
A A61 A61K45/06
A A61 A61K47/10
A A61 A61K47/24
A A61 A61K47/26
A A61 A61N5/10
A A61 A61K2039/505
A A61 A61K2039/545
A A61 A61N2005/1098

Original Patent Information

Patent NumberUS 11,857,627
TitleFractionated radiotherapy and chemotherapy with an oxygen therapeutic
Assignee(s)NuvOx Pharma LLC